Weight-loss Drug Zepbound Eases Sleep Apnea in Company Trials

WEDNESDAY, April 17, 2024 -- Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults in two company trials, drug maker Eli Lilly announced Wednesday.First approved to treat...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news